Page 95 - Read Online
P. 95

Page 10 of 11                       Kaufman et al. J Cancer Metastasis Treat 2019;5:73  I  http://dx.doi.org/10.20517/2394-4722.2019.19

                   with favorable prognosis? A systematic review and meta-analysis. Oral Oncol 2016;54:15-27.
               8.   Nørregaard C, Grønhøj C, Jensen D, Friborg J, Andersen E, et al. Cause-specific mortality in HPV+ and HPV- oropharyngeal cancer
                   patients: insights from a population-based cohort. Cancer Med 2018;7:87-94.
               9.   Sano D, Oridate N. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
                   Int J Clin Oncol 2016;21:819-26.
               10.  Kyrgiou M, Mitra A, Moscicki AB. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res
                   2017;179:168-82.
               11.  Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity 2017;46:562-76.
               12.  Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, et al. The vaginal microbiota, human papillomavirus infection and cervical
                   intraepithelial neoplasia: what do we know and where are we going next? Microbiome 2016;4:58.
               13.  Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, et al. Cervical intraepithelial neoplasia disease progression is associated with
                   increased vaginal microbiome diversity. Sci Rep 2015;5:16865.
               14.  Perera M, Al-Hebshi NN, Speicher DJ, Perera I, Johnson NW. Emerging role of bacteria in oral carcinogenesis: a review with special
                   reference to perio-pathogenic bacteria. J Oral Microbiol 2016;8:32762.
               15.  Al-Hebshi NN, Borgnakke WS, Johnson NW. The microbiome of oral squamous cell carcinomas: a functional perspective. Curr Oral Health
                   Rep 2019;6:145-60.
               16.  Melissaridou S, Wiechec E, Magan M, Jain MV, Chung MK, et al. The effect of 2D and 3D cell cultures on treatment response, EMT profile
                   and stem cell features in head and neck cancer. Cancer Cell Int 2019;19:16.
               17.  Ilhan ZE, Łaniewski P, Thomas N, Roe DJ, Chase DM, et al. Deciphering the complex interplay between microbiota, HPV, inflammation
                   and cancer through cervicovaginal metabolic profiling. EBioMedicine 2019;44:675-90.
               18.  Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/
                   β-catenin modulator Annexin A1. EMBO Rep 2019;20:e47638.
               19.  Mo Y, Wang Y, Zhang L, Yang L, Zhou M, et al. The role of Wnt signaling pathway in tumor metabolic reprogramming. J Cancer
                   2019;10:3789-97.
               20.  Olea-Flores M, Zuñiga-Eulogio MD, Mendoza-Catalán MA, Rodríguez-Ruiz HA, Castañeda-Saucedo E, et al. Extracellular-signal
                   regulated kinase: a central molecule driving epithelial-mesenchymal transition in cancer. Int J Mol Sci 2019;20:e2885.
               21.  Timaner M, Tsai K, Shaked Y. The multifaceted role of mesenchymal stem cells in cancer. Semin Cancer Biol 2019;S1044-579X (19)
                   30135-X.
               22.  Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S, Al Moustafa AE. Epstein-barr virus and human papillomaviruses interactions and their roles in
                   the initiation of epithelial-mesenchymal transition and cancer progression. Front Oncol 2018;8:111.
               23.  Chen X, Bode AM, Dong Z, Cao Y. The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer. FASEB J
                   2016;30:3001-10.
               24.  Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, et al. Epithelial to mesenchymal transition and HPV infection in squamous cell
                   oropharyngeal carcinomas: the papillophar study. Br J Cancer 2017;116:362-9.
               25.  Jiang J, Li X, Yin X, Zhang J, Shi B. Association of low expression of E-cadherin and β-catenin with the progression of early stage human
                   squamous cervical cancer. Oncol Lett 2019;17:5729-39.
               26.  Su PH, Hsu YW, Huang RL, Chen LY, Chao TK, et al. TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent
                   epithelial-mesenchymal transition, in cervical precancerous lesions. Cancer Lett 2019;450:53-62.
               27.  Li MY, Liu JQ, Chen DP, Li ZY, Qi B, et al. p68 prompts the epithelial-mesenchymal transition in cervical cancer cells by transcriptionally
                   activating the TGF-β1 signaling pathway. Oncol Lett 2018;15:2111-6.
               28.  Pang T, Li M, Zhang Y, Yong W, Kang H, et al. Y box-binding protein 1 promotes epithelial-mesenchymal transition, invasion, and
                   metastasis of cervical cancer via enhancing the expressions of Snail. Int J Gynecol Cancer 2017;27:1753-60.
               29.  Kwon MJ, Rho YS, Nam ES, Cho SJ, Park HR, et al. Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar
                   squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition.
                   Hum Pathol 2018;80:28-39.
               30.  Outh-Gauer S, Alt M, Le Tourneau C, Augustin J, Broudin C, et al. Immunotherapy in head and neck cancers: a new challenge for
                   immunologists, pathologists and clinicians. Cancer Treat Rev 2018;65:54-64.
               31.  Zandberg DP, Strome SE. The role of the PD-L1: PD-1 pathway in squamous cell carcinoma of the head and neck. Oral Oncol 2014;50:627-
                   32.
               32.  Ma CT, Luo HS, Gao F, Tang QC, Chen W. Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with
                   E-cadherin. Oncol Lett 2018;16:2606-12.
               33.  Olsen I, Yilmaz Ö. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol 2019;11:1563410.
               34.  Yan X, Liu L, Li H, Qin H, Sun Z. Clinical significance of Fusobacterium nucleatum, epithelial-mesenchymal transition, and cancer stem
                   cell markers in stage III/IV colorectal cancer patients. Onco Targets Ther 2017;10:5031-46.
               35.  Panebianco C, Potenza A, Andriulli A, Pazienza V. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clin
                   Chem Lab Med 2018;56:1400-12.
               36.  Panebianco C, Andriulli A, Pazienza V. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
                   Microbiome 2018;6:92.
               37.  Lee J, Roberts JS, Atanasova KR, Chowdhury N, Han K, et al. Human primary epithelial cells acquire an epithelial-mesenchymal-
                   transition phenotype during long-term infection by the oral opportunistic pathogen, porphyromonas gingivalis. Front Cell Infect Microbiol
                   2017;7:493.
               38.  Sztukowska MN, Ojo A, Ahmed S, Carenbauer AL, Wang Q, et al. Porphyromonas gingivalis initiates a mesenchymal-like transition
                   through ZEB1 in gingival epithelial cells. Cell Microbiol 2016;18:844-58.
   90   91   92   93   94   95   96   97   98   99   100